Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential

Author(s): Zachary I


Vascular endothelial growth factor (VEGF or VEGF-A) and its receptors play essential roles in the formation of blood vessels during embryogenesis and in disease. Most biological effects of VEGF are mediated via two receptor tyrosine kinases, VEGFR1 and VEGFR2, but specific VEGF isoforms also bind neuropilins (NP) 1 and 2, non-tyrosine kinase receptors originally identified as receptors for semaphorins, polypeptides with essential roles in neuronal patterning. There is abundant evidence that VEGF-A has neurotrophic and neuroprotective effects on neuronal and glial cells in culture and in vivo, and can stimulate the proliferation and survival of neural stem cells. VEGFR2 and NP1 are the major VEGF receptors expressed on neuronal cells and, while the mechanisms mediating neuroprotective effects of VEGF are not fully understood, VEGF stimulates several signalling events in neuronal cell types, including activation of phospholipase C-gamma, Akt and ERK. Findings in diverse models of nerve damage and disease suggest that VEGF has therapeutic potential as a neuroprotective factor. VEGF is a key mediator of the angiogenic response to cerebral and peripheral ischaemia, and promotes nerve repair following traumatic spinal injury. Recent work has revealed a role for reduced VEGF expression in the pathogenesis of amyotrophic lateral sclerosis, a rare neurodegenerative disease caused by selective loss of motor neurons. In many instances, the neuroprotective effects of VEGF appear to result from a combination of the indirect consequences of increased angiogenesis, and the direct stimulation of neuronal function. However, more work is required to determine the specific functional role of direct neuronal effects of VEGF.

Similar Articles

Plasmatic markers for early diagnostic and treatment decisions in ischemic stroke

Author(s): Stanca DM, Mărginean IC, Soriţău O, Mureșanu DF

Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging

Author(s): Higashi Y, Quevedo HC, Tiwari S, Sukhanov S, Shai SY, et al.

Trophic factors as modulators of motor neuron physiology and survival: implications for ALS therapy

Author(s): Tovar-Y-Romo LB, Ramírez-Jarquín UN, Lazo-Gómez R, Tapia R

The Barthel ADL Index: a reliability study

Author(s): Collin C, Wade DT, Davies S, Horne V

Individual predictors of sensorimotor adaptability

Author(s): Seidler RD, Mulavara AP, Bloomberg JJ, Peters BT

Potential predictors of lower extremity impairments in motor coordination of stroke survivors

Author(s): Menezes KK, Scianni AA, Faria-Fortini I, Avelino PR, Carvalho AC, et al.